Summary slide.png (137.39 kB)

Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial

figure

posted on 2020-09-18, 10:31 authored by Danyal Ibrahim, Latha Dulipsingh, Lisa Zapatka, Reginald Eadie, Rebecca Crowell, Kendra Williams, Dorothy B. Wakefield, Lisa Cook, Jennifer Puff, Syed A. Hussain

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

Usage metrics

Infectious Diseases and Therapy

Keywords

Adult respiratory distress syndrome COVID-19 COVID-19 serotherapy Hospital mortality Length of stay Phase II clinical trial Plasma Prospective Studies Severe acute respiratory syndrome coronavirus 2 Ventilation

Licence

CC BY-NC 4.0

Factors Associated with Good Patient Outcomes Following Convalescent Plasma in COVID-19: A Prospective Phase II Clinical Trial

History

Usage metrics

Categories

Keywords

Licence

Exports